LOGIN
Ropivacaine With Methylene Blue For Fascia Iliaca Block In Hip Arthroplasty
August 2025
Ropivacaine With Methylene Blue For Fascia Iliaca Block In Hip Arthroplasty
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Analgesic effect of ropivacaine combined with methylene blue in fascia Iliaca block for patients undergoing hip arthroplasty.
BMC Musculoskelet Disord . 2025 Mar 14;26(1):256.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Ninety patients undergoing THA were randomized to receive fascia iliaca compartment block (FICB) with ropivacaine + methylene blue (MB) (n=45) or ropivacaine alone (n=45). The primary outcome was VAS pain (rest and activity), with the 48 h VAS prespecified as primary. Secondary outcomes included hs‑CRP, procalcitonin, neutrophil‑to‑lymphocyte ratio, heart rate/mean arterial pressure, supplemental ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.